BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15688099)

  • 21. Apoptosis-associated proteins in oral hairy leukoplakia.
    Chrysomali E; Greenspan JS; Dekker N; Greenspan D; Regezi JA
    Oral Dis; 1996 Dec; 2(4):279-84. PubMed ID: 9171511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis and bcl-2 expression as predictors of survival in radiation-treated non-small-cell lung cancer.
    Hwang JH; Lim SC; Kim YC; Park KO; Ahn SJ; Chung WK
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):13-8. PubMed ID: 11316541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
    Lu DW; El-Mofty SK; Wang HL
    Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fas expression is associated with a better prognosis in laryngeal squamous cell carcinoma.
    Asensio C; Zapata A; García-Ahijado J; Gil B; Salvadores P; Schneider J
    Anticancer Res; 2007; 27(6B):4083-6. PubMed ID: 18225575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulators of proliferation and apoptosis in carcinoma of the larynx.
    Whisler LC; Wood NB; Caldarelli DD; Hutchinson JC; Panje WR; Friedman M; Preisler HD; Leurgans S; Nowak J; Coon JS
    Laryngoscope; 1998 May; 108(5):630-8. PubMed ID: 9591537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bag-1 expression as a prognostic factor in tongue squamous cell carcinomas.
    Xie X; Clausen OP; Boysen M
    Laryngoscope; 2004 Oct; 114(10):1785-90. PubMed ID: 15454773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. bcl-2 and p53 immunophenotypes in pre-invasive, early and advanced oesophageal squamous cancer.
    Parenti AR; Rugge M; Shiao YH; Ruol A; Ancona E; Bozzola L; Ninfo V
    Histopathology; 1997 Nov; 31(5):430-5. PubMed ID: 9416483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.
    Giarnieri E; Mancini R; Pisani T; Alderisio M; Vecchione A
    Clin Cancer Res; 2000 Sep; 6(9):3600-6. PubMed ID: 10999751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological analysis of basal cell carcinoma of the anal region and its distinction from basaloid squamous cell carcinoma.
    Patil DT; Goldblum JR; Billings SD
    Mod Pathol; 2013 Oct; 26(10):1382-9. PubMed ID: 23599161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
    Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
    Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between expression of p53/bcl-2 and clinicopathological criteria in cervix squamous cell carcinomas.
    Bitiren M; Cakmak EA; Gocmen A; Inaloz SS; Sari I; Karakok M; Aydin A
    Eur J Gynaecol Oncol; 2003; 24(5):411-2. PubMed ID: 14584658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of p53, p21 and bcl-2 in prognosis of lung carcinomas].
    Nhung NV; Mirejovský T; Mirejovský P; Melínová L
    Cesk Patol; 1999 Oct; 35(4):117-21. PubMed ID: 10677910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
    Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
    Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proliferation and p53 expression in anal cancer precursor lesions.
    Mullerat J; Deroide F; Winslet MC; Perrett CW
    Anticancer Res; 2003; 23(3C):2995-9. PubMed ID: 12926152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Protein expression of p53, bcl-2, and bax in adenoid cystic carcinoma of lacrimal gland].
    You JQ; Wang P
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1978-82. PubMed ID: 19062739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
    Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
    Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of Bak expression in oral tongue squamous cell carcinomas.
    Xie X; Clausen OP; Boysen M
    Oncol Rep; 2003; 10(2):369-74. PubMed ID: 12579274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis Phenomena in Squamous Cell Carcinomas and Adenocarcinomas of the Uterine Cervix.
    Eduardo MG; Campaner AB; Silva MA
    Pathol Oncol Res; 2015 Sep; 21(4):887-92. PubMed ID: 25682239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Squamous cell carcinoma of the tongue: the prevalence and prognostic roles of p53, Bcl-2, c-erbB-2 and apoptotic rate as related to clinical and pathological characteristics in a retrospective study.
    Nagler RM; Kerner H; Laufer D; Ben-Eliezer S; Minkov I; Ben-Itzhak O
    Cancer Lett; 2002 Dec; 186(2):137-50. PubMed ID: 12213283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.